SEVERE OBESITY IS ASSOCIATED WITH WORSE OUTCOMES THAN LEAN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A POPULATION-BASED COHORT STUDY

被引：0
|
作者：
Behari, Jaideep
Wang, Renwei
Luu, Hung N.
McKenzie, David
Molinari, Michele
Yuan, Jian-Min
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1609
引用
收藏
页码：S1662 / S1662
页数：1
相关论文
共 50 条
  • [31] Genetic predisposition of metabolic dysfunction-associated steatotic liver disease: a population-based genome-wide association study
    Wang, Shao-Wen
    Wang, Ching
    Cheng, Yu-Ming
    Chen, Chun-Yi
    Hsieh, Tsung-Han
    Wang, Chia-Chi
    Kao, Jia-Horng
    HEPATOLOGY INTERNATIONAL, 2025, : 415 - 427
  • [32] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [33] Incidence of metabolic dysfunction-associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study
    Kim, Kunhee
    Lee, Yaeji
    Lee, Jae Seung
    Kim, Mi Na
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Jung, Inkyung
    Lee, Hye Won
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (12) : 2845 - 2852
  • [34] Enhanced long-term outcomes with laparoscopic bariatric surgery in patients with severe obesity and metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study
    Zhang, Xinrong
    Rouillard, Nicholas
    Mao, Xianhua
    Lat, Rongtao
    Cheung, Ramsey
    Sasaki, Kazunari
    Nguyen, Mindie H.
    HEPATOBILIARY SURGERY AND NUTRITION, 2025,
  • [35] Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Barbera, Aurora
    White, Trenton M.
    Arora, Anish K.
    Henry, Linda
    Lazarus, Jeffrey V.
    Younossi, Zobair M.
    SEMINARS IN LIVER DISEASE, 2024,
  • [36] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [37] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
    Eskridge, Wayne
    Cryer, Donna R.
    Schattenberg, Joern M.
    Gastaldelli, Amalia
    Malhi, Harmeet
    Allen, Alina M.
    Noureddin, Mazen
    Sanyal, Arun J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [38] Metabolic dysfunction-associated steatotic liver disease, liver fibrosis and risk of cardiovascular disease: A prospective cohort study
    Baek, Ji Woo
    Yang, Yeun Soo
    Jung, Keum Ji
    Kimm, Heejin
    Kim, So Young
    Lee, Sunmi
    Jee, Sun Ha
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (12) : 2623 - 2629
  • [39] Metabolic dysfunction-associated steatotic liver disease is a risk factor for gallstones: A multicenter cohort study
    Cho, Tomonori
    Fukunaga, Shuhei
    Ohzono, Daiki
    Tanaka, Hiroshi
    Minami, Shinpei
    Nakane, Tomoyuki
    Mukasa, Michita
    Yoshinaga, Shinobu
    Nouno, Ryuichi
    Takedatsu, Hidetoshi
    Kawaguchi, Takumi
    HEPATOLOGY RESEARCH, 2025,
  • [40] ASSOCIATION BETWEEN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND MORTALITY: A NATIONWIDE COHORT STUDY
    Kim, Gi-Ae
    Park, Yewan
    Jung, Jooyi
    HEPATOLOGY, 2024, 80 : S880 - S880
12345